Advertisement
Cancer scientist Feng Gensheng leaves US for China as Trump cuts funding
Feng, whose work focuses on liver cancer and immunotherapy, will lead research institute at Shenzhen Bay Laboratory after 40 years abroad
Reading Time:2 minutes
Why you can trust SCMP
3
Distinguished cancer expert Feng Gensheng has returned to China this month after 40 years in North America, mostly in the United States.
Feng, who was promoted to distinguished professor at the University of California, San Diego (UCSD) earlier this year, has joined the Shenzhen Bay Laboratory (SZBL), where he will serve as director of the Cancer Research Institute.
SZBL is a research platform established by Guangdong province and the southern city of Shenzhen to build leading science and technology innovation centres.
Advertisement
Feng’s research focuses on the mechanisms of liver cancer recurrence and immunotherapy for liver cancer. His most important contribution to the field is the discovery of SHP2, a new kind of enzyme.
This type of enzyme can affect the stability of proteins and regulate the activity of other enzymes, which helps us understand the regeneration and differentiation mechanisms of various cells.
Advertisement
Feng, a fellow of the American Association for the Advancement of Science (AAAS), confirmed he had returned to China.
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x